Importance of high radiation doses (72 Gy or greater) in the treatment of Stage T1-T3 adenocarcinoma of the prostate
- 1 January 2000
- journal article
- clinical trial
- Published by Elsevier BV in Urology
- Vol. 55 (1), 85-90
- https://doi.org/10.1016/s0090-4295(99)00380-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- IMPROVEMENT IN OVERALL SURVIVAL FOR PATIENTS WITH LOCALIZED PROSTATE CANCER WITH HIGHER THAN STANDARD RADIATION DOSESJournal of Urology, 1999
- Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directionsInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Androgen ablation in addition to radiation therapy for prostate cancer: Is there true benefit?Seminars in Radiation Oncology, 1998
- External beam radiotherapy for stage T1/T2 prostate cancer: how does it stack up?Urology, 1998
- External beam radiotherapy dose response of prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinNew England Journal of Medicine, 1997
- Indications for excluding the seminal vesicles when treating clinically localized prostatic adenocarcinoma with radiotherapy aloneInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Conventional vs. conformal radiotherapy for prostate cancer: Preliminary results of dosimetry and acute toxicityInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology groupUrology, 1995